PurposeTo study the possible pharmacokinetic and pharmacodynamic interactions between irinotecan and methimazole.MethodsA patient treated for colorectal cancer with single agent irinotecan received methimazole co-medication for Graves’ disease. Irinotecan pharmacokinetics and side effects were fo…